BTC Capital Management Inc. lifted its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 6.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,476 shares of the company’s stock after acquiring an additional 3,293 shares during the period. Johnson & Johnson makes up 1.3% of BTC Capital Management Inc.’s holdings, making the stock its 19th biggest holding. BTC Capital Management Inc.’s holdings in Johnson & Johnson were worth $7,345,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. AllSquare Wealth Management LLC purchased a new position in Johnson & Johnson during the third quarter worth about $867,000. CIBC Asset Management Inc boosted its holdings in Johnson & Johnson by 8.6% during the third quarter. CIBC Asset Management Inc now owns 398,725 shares of the company’s stock worth $51,838,000 after purchasing an additional 31,681 shares during the last quarter. Papp L Roy & Associates boosted its holdings in Johnson & Johnson by 2.1% during the third quarter. Papp L Roy & Associates now owns 87,150 shares of the company’s stock worth $11,330,000 after purchasing an additional 1,761 shares during the last quarter. Cobblestone Capital Advisors LLC NY boosted its holdings in Johnson & Johnson by 0.9% during the third quarter. Cobblestone Capital Advisors LLC NY now owns 103,018 shares of the company’s stock worth $13,393,000 after purchasing an additional 917 shares during the last quarter. Finally, Cliftonlarsonallen Wealth Advisors LLC boosted its holdings in Johnson & Johnson by 3.9% during the third quarter. Cliftonlarsonallen Wealth Advisors LLC now owns 11,315 shares of the company’s stock worth $1,471,000 after purchasing an additional 420 shares during the last quarter. 65.70% of the stock is owned by institutional investors.

Several research firms recently weighed in on JNJ. Vetr cut shares of Johnson & Johnson from a “hold” rating to a “sell” rating and set a $129.62 price target on the stock. in a report on Friday, October 13th. Stifel Nicolaus boosted their price target on shares of Johnson & Johnson from $140.00 to $142.00 and gave the stock a “hold” rating in a report on Wednesday, October 18th. JPMorgan Chase & Co. cut shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. BMO Capital Markets boosted their target price on shares of Johnson & Johnson to $161.00 and gave the company an “outperform” rating in a research note on Tuesday, December 12th. Finally, BTIG Research reiterated a “sell” rating and issued a $110.00 target price on shares of Johnson & Johnson in a research note on Wednesday, January 24th. Four analysts have rated the stock with a sell rating, eight have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $146.16.

Johnson & Johnson (NYSE:JNJ) opened at $126.36 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02. The firm has a market cap of $339,470.00, a PE ratio of 324.00, a price-to-earnings-growth ratio of 2.37 and a beta of 0.74. Johnson & Johnson has a 52 week low of $113.40 and a 52 week high of $148.32.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Tuesday, January 23rd. The company reported $1.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.72 by $0.02. The firm had revenue of $20.20 billion for the quarter, compared to analysts’ expectations of $20.08 billion. Johnson & Johnson had a net margin of 1.70% and a return on equity of 27.80%. The company’s quarterly revenue was up 11.5% on a year-over-year basis. During the same period in the previous year, the company earned $1.58 earnings per share. equities research analysts anticipate that Johnson & Johnson will post 8.08 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be paid a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.66%. The ex-dividend date is Monday, February 26th. Johnson & Johnson’s payout ratio is currently 861.54%.

TRADEMARK VIOLATION NOTICE: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.watchlistnews.com/btc-capital-management-inc-acquires-3293-shares-of-johnson-johnson-jnj/1854127.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.